Clinical Trial Results: Positive clinical trial outcomes typically boost investor confidence and drive up the stock price. Conversely, failed or delayed trials can negatively impact the stock.

Regulatory Approvals: Successful approval of Afmd's product candidates by regulatory agencies like the FDA can lead to increased stock value.

Partnerships and Collaborations: Strategic alliances with larger pharmaceutical companies or research institutions often signal validation of Afmd's technology and can influence stock performance.

Market Sentiment: Overall market conditions and investor sentiment towards the biotechnology sector can affect Afmd's stock price, regardless of company-specific news.

Financial Performance: Afmd's cash position, revenue generation, and expenses influence investor perception and stock valuation. Strong financial results typically lead to increased confidence.

Competition: The presence of competing therapies or companies in the same therapeutic area can impact Afmd's market share and stock price.